Our mission is to improve the quality of life for patients with unmet medical needs through the development and production of the highest quality pharmaceutical products and therapies derived from Medicinal Cannabis
From plant to patient
1
Cultivation & Production
- GMP certified state of the art growing facility
- Innovative growing techniques and technology
- Sustainability
2
Product Development
- Innovative products derived from clinical development activities
- Precisely formulated cannabinoid products
- Innovative delivery systems
- Enhancing cultivation and manufacturing processes
3
Manufacturing
- Elite genetic strains tailored to health conditions
- High-end extraction and analysis technology
4
Research & Development
- Selecting and enhancing elite genetics and tissue culture
- Clinical Studies and trials
- Clinical investigations into a variety of health conditions
- Partnerships and Collaborations
Three 6 Zero
Products
Our mission is to improve the quality of life for patients with unmet medical needs through the development and production of the highest quality pharmaceutical drugs and therapies derived from Medicinal Cannabis
We are committed to the development of innovative medicinal cannabis products
GSM's ongoing product development program is paving the way for exclusive formulated cannabinoid products through our advanced genetics program to treat specific health conditions.
Evidence-based Statistics
Unveiling the Medicinal Marijuana Landscape
64%
reported experiencing significant pain relief
A study published in the New England Journal of Medicine found that CBD reduced the frequency of seizures in children with a rare form of epilepsy by 23%
Join the 360 Community
PTSD symptoms
A study published in the Journal of Psychoactive Drugs found that medical marijuana use was associated with a 75% reduction in PTSD symptoms
Epilepsy
A study published in the Journal of Psychoactive Drugs found that medical marijuana use was associated with a 75% reduction in PTSD symptoms
A study published in the New England Journal of Medicine found that CBD reduced the frequency of seizures in children with a rare form of epilepsy by 23%
*It’s important to note that while there is promising research on the benefits of medicinal marijuana, more research is needed to fully understand its potential uses and effects. Additionally, it’s important to consult with a healthcare provider before using medicinal marijuana or CBD oil as a treatment.
The Facility
Green Scope Medicinal’s (GSM) GMP facility is situated in a prime rural suburb of Sydney NSW. GSM’s current 20,569 square foot facility encompasses our cultivation and manufacturing operations. The facility is one of seven greenhouse structures on the property which all share a similar footprint. Our expansion plan will utilise all seven greenhouse structures situated on 143, 983 square feet. The remaining six greenhouses will be retrofitted to become GMP certified state-of-the-art facilities encompassing Cultivation, Manufacturing and will also include Research & Development operations.
Security
Green Scope Medicinal (GSM) aim to be the benchmark when it comes to securing our GMP certified facility in this emerging industry. GSM’s facility design will implement leading state-of-the-art technology combined with dynamic procedures to mitigate risk and ensure an efficient operation.
GSM’s facility will utilise industry leading technology in alarm systems, motion sensors, CCTV, physical deterrents and controlled access points to safeguard staff and the facility.
Licenses & Regulatory
Compliance
Department of Health Office of Drug Control
Cannabis Research Licence
Green Scope Medicinal operates as the license holder, engaging in a collaborative partnership with its subsidiary, Three 6 Zero. Together, they manage all aspects of sales and marketing, seamlessly integrating their efforts within the corporate framework for optimal operational synergy.
Green Scope Medicinal are audited and accredited by the Australian Therapeutic Goods Administration and the Department of Health Office of Drug Control. GSM currently holds a license to Cultivate and Manufacturing Medicinal Cannabis. Phase 3 will include an additional GMP certified Research & Development license expected to be issued Q1 of 2024.
Corporate Social Responsibility
Green Scope Medicinal (GSM) believes in being socially responsible and giving back to the community. GSM also seeks to engage in sustainable practices and minimize its environmental impact through its cultivation, manufacturing, and product development processes. This includes initiatives such as using renewable energy sources, reducing waste and carbon emissions, and promoting eco-friendly packaging. GSM is committed to being a responsible corporate citizen and making a positive difference in the world.
Future Developments
Green Scope Medicinal is an innovative Australian based fully integrated pharmaceutical medicinal cannabis company. GSM are in phase two of a three phase set up to become the finest producer and supplier of a diverse range of medicinal cannabis products, treatments, and services globally.
GSM aims to contribute to the understanding of Medicinal Cannabis through various clinical programs to collate supporting data amid at patients with unmet medical needs. Clinical trials will also pave the way for innovation by enhancing GSM’s manufacturing and product development capabilities to ultimately improve the quality of life for millions of people around the world.
Take the High Road to Healing
Sign up to our newsletter and discover the plants Medicinal Powers.
Sign up and Stay in the know
